Palisade Bio Dividend
Dividend criteria checks 0/6
Palisade Bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$14.47 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Palisade Bio announces CEO transition
Oct 11Palisade Bio streamlines operations, including cutting 20% of employees
Sep 15Palisade Bio GAAP EPS of -$0.12
Aug 15Palisade Bio begins phase 3 study testing LB1148 for postoperative return of bowel function
Jul 27Palisade Bio rises 10% after starting phase 3 study of gastrointestinal surgery therapy
Jun 29Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely
Mar 28Palisade Bio: Guarding Intestinal Integrity
Nov 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PALI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PALI's dividend payments have been increasing.
Dividend Yield vs Market
Palisade Bio Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (PALI) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Pharmaceuticals) | 2.3% |
Analyst forecast in 3 Years (PALI) | n/a |
Notable Dividend: Unable to evaluate PALI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PALI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate PALI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PALI has not reported any payouts.